Navigation Links
Final flight of space shuttle Discovery to carry 2 payloads built by CU-Boulder
Date:2/15/2011

Following a more than three-month delay due to technical problems, NASA's space shuttle Discovery will make its final flight Feb. 24 from Kennedy Space Center in Florida carrying two University of Colorado Boulder-built biomedical payload devices.

One of the experiments is designed to help scientists better understand changes in the virulence of bacteria in the low gravity of space as a way to help researchers prevent or control infectious diseases. The second is a cell cultivation experiment in a tropical plant known to produce nuts that could be used to make biofuels, said Louis Stodieck, director of BioServe Space Technologies in CU-Boulder's aerospace engineering sciences department.

Both experiments will be carried aboard Discovery in sets of specially designed fluid-processing cylinders built by BioServe known as GAPs, said Stodieck, The bacteria experiment will target how microgravity affects the growth of bacteria, in this case Methicillin-Resistant Staphylococcus Aureus, also known as MRSA.

The GAPs will ride inside BioServe's Commercial Generic Bioprocessing Apparatus, an automated, suitcase-sized device developed at CU-Boulder that has been launched on more than 20 NASA space shuttle missions, with two of the CGBA devices now on the International Space Station. BioServe is providing the hardware, integration and operations support for all Discovery GAP experiments.

Astronauts will control the individual GAP experiments using hand cranks to trigger and then later terminate cell growth via fluid mixing, said Stodieck. The samples will remain on the space station until the next shuttle mission slated to launch at the end of February, at which time they will be returned to Earth for further study.

The bacterial experiment is sponsored by Astrogenetix Inc. headquartered in Austin, Texas, and designed by researchers at the Durham VA Medical Center in North Carolina. MRSA is a growing problem in hosp
'/>"/>

Contact: Louis Stodieck
stodieck@colorado.edu
303-492-4010
University of Colorado at Boulder
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Finalists announced in the Elsevier Grand Challenge
2. Substantial work ahead for water issues, say scientists at ACS Final Report briefing
3. Final frontier: Mission to explore buried ancient Antarctic lake given green light
4. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
5. Cements basic molecular structure finally decoded
6. TGen finalizes alliance with Van Andel Research Institute
7. Finally, an excuse for pregnant women to eat bacon and eggs
8. Final moments of bee landing tactics revealed
9. U of Minnesota finalizes license agreement to form start-up company based on Doris Taylor research
10. Scientists discover final piece in phytate jigsaw
11. The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Final flight of space shuttle Discovery to carry 2 payloads built by CU-Boulder
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... may help us breed and select plants that would better ... The paper, which offers the first example of a gene ... the July 12 issue of Current Biology. "It's very exciting," ... Campbell. "This is a gene that helps regulate carbon dioxide ...
... to cause a dangerous nerve condition called neuropathy that ... led by Baylor College of Medicine in Houston. , ... Medical Science in Japan, and the University of Chicago ... Academy of Sciences. , The finding not only provides ...
... vast ecosystem beneath the collapsed Larsen Ice Shelf will ... floating ice shelves and further probe the origins of ... after a recent underwater video study examining a deep ... sudden Larsen B shelf collapse in 2002. , "This ...
Cached Biology News:Genetic discovery could lead to drought-resistant plants 2Malfunctioning bone marrow cells sabotage nerve cells in diabetes 2Discovering an ecosystem beneath a collapsed Antarctic ice shelf 2
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... will hold its 2015 Annual Meeting of Stockholders on ... the expected date for the Annual Meeting represents a ...
(Date:12/24/2014)... On Friday, December 19, 2014, ... Omnibus and Continuing Resolution Appropriations Act of 2015, ... condition eligible to receive funding through the Congressionally ... Department of Defense (DoD). The Hydrocephalus Association (HA), ... Hill, is celebrating this victory for the over ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... a Clinical Trial Application (CTA) with the ... (MHRA) seeking regulatory approval to initiate clinical trials for ... Contingent on the Company receiving CTA regulatory ... trial to assess the safety, tolerability and dose escalation ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... June 25, 2009 Veritide Ltd., a developer of ... new independent data to be presented at the Biodetection ... Ceeker (pronounced "seeker") portable bacterial detection device in discriminating ... data show that in over two weeks of testing ...
... SAN MARINO, Calif., July 8 Biotechnology company Viral ... financial disclosures through the OTCIQ.com portal, that provides information ... website. The website is an online point of ... Sheets" over-the-counter market. Investors can access and download all ...
... , SAN FRANCISCO, July 8 Nile Therapeutics, Inc. (Nasdaq: ... of novel therapeutics for heart failure patients, today announced that ... private placement securities of the Company for aggregate gross proceeds ... broker dealer, acted as the exclusive placement agent for the ...
Cached Biology Technology:Novel handheld device detects anthrax with outstanding accuracy and reliability 2Novel handheld device detects anthrax with outstanding accuracy and reliability 3Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website 2Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website 3Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 2Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 3Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 4